258 related articles for article (PubMed ID: 18839616)
1. [Concentration of osteoprotegerin, bone formation and resorption markers in patients with phenylketonuria].
Ambroszkiewicz J; Gajewska J; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Nowacka M; Milanowski A
Pol Merkur Lekarski; 2008 Jul; 25(145):57-60. PubMed ID: 18839616
[TBL] [Abstract][Full Text] [Related]
2. Osteoprotegerin and C-telopeptide of type I collagen in Polish healthy children and adolescents.
Gajewska J; Ambroszkiewicz J; Laskowska-Klita T
Adv Med Sci; 2006; 51():269-72. PubMed ID: 17357324
[TBL] [Abstract][Full Text] [Related]
3. Serum markers of bone turnover in children and adolescents with classic galactosemia.
Gajewska J; Ambroszkiewicz J; Radomyska B; Chełchowska M; Ołtarzewski M; Laskowska-Klita T; Milanowski A
Adv Med Sci; 2008; 53(2):214-20. PubMed ID: 18650146
[TBL] [Abstract][Full Text] [Related]
4. [Markers of bone formation and resorption in prepubertal children with phenylketonuria].
Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
Med Wieku Rozwoj; 2003; 7(1):89-95. PubMed ID: 13130173
[TBL] [Abstract][Full Text] [Related]
5. Implications of measuring soluble receptor activators of nuclear factor-kappaB ligand and osteoprotegerin in bone metabolism of elderly women.
Chiba Y; Onouchi T; Ikeda T; Adachi J; Tamura Y; Horiuchi T
Gerontology; 2009; 55(3):275-80. PubMed ID: 19158438
[TBL] [Abstract][Full Text] [Related]
6. Effect of acute citrate load on markers of bone metabolism in healthy volunteers.
Chen Y; Bieglmayer C; Höcker P; Dettke M
Vox Sang; 2009 Nov; 97(4):324-9. PubMed ID: 19508702
[TBL] [Abstract][Full Text] [Related]
7. Markers of bone metabolism in eugonadal female patients with beta-thalassemia major.
Angelopoulos NG; Goula A; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Konstandelou E; Tolis G
Pediatr Hematol Oncol; 2007; 24(7):481-91. PubMed ID: 17786784
[TBL] [Abstract][Full Text] [Related]
8. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin in men with thyroid cancer.
Mikosch P; Igerc I; Kudlacek S; Woloszczuk W; Gallowitsch HJ; Kresnik E; Stettner H; Grimm G; Lind P; Pietschmann P
Eur J Clin Invest; 2006 Aug; 36(8):566-73. PubMed ID: 16893379
[TBL] [Abstract][Full Text] [Related]
9. Effect of zoledronic acid on markers of bone turnover and mineral density in osteoporotic patients with beta-thalassaemia.
Perifanis V; Vyzantiadis T; Tziomalos K; Vakalopoulou S; Garipidou V; Athanassiou-Metaxa M; Harsoulis F
Ann Hematol; 2007 Jan; 86(1):23-30. PubMed ID: 17013645
[TBL] [Abstract][Full Text] [Related]
10. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
[TBL] [Abstract][Full Text] [Related]
11. [Assessment of selected bone metabolism marker concentrations in children with cystic fibrosis].
Ambroszkiewicz J; Gajewska J; Sands D; Chełchowska M; Ołtarzewski M; Laskowska-Klita T
Med Wieku Rozwoj; 2012; 16(2):117-23. PubMed ID: 22971655
[TBL] [Abstract][Full Text] [Related]
12. Does serum osteoprotegerin level relate to fragility fracture in elderly women with low vitamin D status?
Sypniewska G; Sobanska I; Pater A; Kedziora-Kornatowska K; Nowacki W
Med Sci Monit; 2010 Feb; 16(2):CR96-101. PubMed ID: 20110921
[TBL] [Abstract][Full Text] [Related]
13. Alterations in circulating osteoimmune factors may be responsible for high bone resorption rate in HIV-infected children and adolescents.
Mora S; Zamproni I; Cafarelli L; Giacomet V; Erba P; Zuccotti G; Viganò A
AIDS; 2007 May; 21(9):1129-35. PubMed ID: 17502723
[TBL] [Abstract][Full Text] [Related]
14. Increased formation of 8-iso-prostaglandin F(2alpha) is associated with altered bone metabolism and lower bone mass in hypercholesterolaemic subjects.
Mangiafico RA; Malaponte G; Pennisi P; Li Volti G; Trovato G; Mangiafico M; Bevelacqua Y; Mazza F; Fiore CE
J Intern Med; 2007 Jun; 261(6):587-96. PubMed ID: 17547714
[TBL] [Abstract][Full Text] [Related]
15. Body mass index and disease duration are predictors of disturbed bone turnover in anorexia nervosa. A case-control study.
Weinbrenner T; Zittermann A; Gouni-Berthold I; Stehle P; Berthold HK
Eur J Clin Nutr; 2003 Oct; 57(10):1262-7. PubMed ID: 14506487
[TBL] [Abstract][Full Text] [Related]
16. [Concentrations of serum bone turnover markers in smoking pregnant women and in umbilical cord blood of newborns].
Ambroszkiewicz J; Maciejewski T; Chełchowska M; Gajewska J; Laskowska-Klita T
Przegl Lek; 2009; 66(10):644-7. PubMed ID: 20301901
[TBL] [Abstract][Full Text] [Related]
17. Fish liver oil and propolis as protective natural products against the effect of the anti-epileptic drug valproate on immunological markers of bone formation in rats.
Elwakkad AS; El Elshamy KA; Sibaii H
Epilepsy Res; 2008 Jul; 80(1):47-56. PubMed ID: 18455911
[TBL] [Abstract][Full Text] [Related]
18. Changes of clinical response and bone biochemical markers in patients with ankylosing spondylitis taking etanercept.
Woo JH; Lee HJ; Sung IH; Kim TH
J Rheumatol; 2007 Aug; 34(8):1753-9. PubMed ID: 17610317
[TBL] [Abstract][Full Text] [Related]
19. Bone turnover markers, osteoprotegerin and RANKL cytokines in children with cystic fibrosis.
Ambroszkiewicz J; Sands D; Gajewska J; Chelchowska M; Laskowska-Klita T
Adv Med Sci; 2013; 58(2):338-43. PubMed ID: 24277958
[TBL] [Abstract][Full Text] [Related]
20. The influence of weight loss on serum osteoprotegerin concentration in obese perimenopausal women.
Holecki M; Zahorska-Markiewicz B; Janowska J; Nieszporek T; Wojaczyńska-Stanek K; Zak-Gołab A; Wiecek A
Obesity (Silver Spring); 2007 Aug; 15(8):1925-9. PubMed ID: 17712108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
